Group A: ≥ 10 (n = 1129, 52.2%) | Group B: ≥ −10 to < 10 (n = 887, 41.0%) | Group C: < −10 (n = 145, 6.7%) | p-value | ||||
---|---|---|---|---|---|---|---|
for all | A vs. B | A vs. C | B vs. C | ||||
Age (years) | 78.0 ± 8.7 | 74.8 ± 8.7 | 73.2 ± 8.5 | < 0.001a | < 0.001b | < 0.001b | 0.106b |
Male, n (%) | 174 (15.4%) | 80 (9.0%) | 15 (10.3%) | < 0.001c | < 0.001d | 0.406d | > 0.999d |
BMI > 30 kg/cm2, n (%) | 20 (1.8%) | 11 (1.2%) | 16 (0.7%) | 0.528c | |||
Current smoking, n (%) | 38 (3.4%) | 37 (4.2%) | 10 (6.9%) | 0.111c | |||
High alcohol comsumption, n (%) | 35 (3.1%) | 23 (2.6%) | 2 (1.4%) | 0.542c | |||
Diabetes mellitus, n (%) | 150 (13.3%) | 79 (8.9%) | 13 (9.0%) | 0.006c | 0.007d | 0.556d | > 0.999d |
Corticosteroid use, n (%) | 156 (13.8%) | 99 (11.2%) | 15 (10.3%) | 0.154c | |||
Rheumatoid arthritis, n (%) | 100 (8.9%) | 64 (7.2%) | 17 (6.9%) | 0.376c | |||
Percentage of YAM at LS (%) | 87.9 ± 18.3 | 70.5 ± 13.3 | 63.1 ± 10.4 | < 0.001a | < 0.001b | < 0.001b | < 0.001b |
Percentage of YAM at FN (%) | 64.3 ± 14.6 | 69.6 ± 13.1 | 79.3 ± 12.0 | < 0.001a | < 0.001b | < 0.001b | < 0.001b |